Is CollPlant Biotechnologies Ltd. (CLGN) a Buy, Sell, or Hold?
CollPlant Biotechnologies Ltd.
NASDAQ:CLGN
$0.3489 USD
-$0.02 (-4.41%)
- Volume
- 26.56K
- Average Volume
- 76.44K
- Market Capitalization
- $4.52M
- P/E Ratio
- -0.34
- Dividend Yield
- 0.00%
- Price Target
- $12.50
- Year High
- $3.23
- Year Low
- $0.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.27
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
0
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
-$
CLGN Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CLGN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Evans Hugh M | director | 2026-03-18 | 0 | 2026-04-27 | |
| Evans Hugh M | director | 2026-03-18 | 0 | 2026-04-27 | |
| Evans Hugh M | director | 2026-03-18 | 0 | 2026-04-27 | |
| Evans Hugh M | director | 2026-03-18 | 0 | 2026-04-27 | |
| Evans Hugh M | director | 2023-05-02 | 6.39 | 2026-04-27 | |
| Tal Yehiel | director, officer: Chief Executive Officer | 2026-03-19 | 0 | 2026-03-19 | |
| Tal Yehiel | director, officer: Chief Executive Officer | 2026-03-19 | 0 | 2026-03-19 | |
| Tal Yehiel | director, officer: Chief Executive Officer | 2023-05-02 | 6.39 | 2026-03-19 | |
| Tal Yehiel | director, officer: Chief Executive Officer | 2020-05-18 | 4.02 | 2026-03-19 | |
| Lask Alisa | director | 2026-03-18 | 0 | 2026-03-18 | |
| Lask Alisa | director | 2023-05-02 | 6.39 | 2026-03-18 | |
| Penn Elan | director | 2026-03-18 | 0 | 2026-03-18 | |
| Penn Elan | director | 2019-01-14 | 4.02 | 2026-03-18 | |
| Penn Elan | director | 2023-05-02 | 6.39 | 2026-03-18 | |
| Havron Avraham | director | 2026-03-18 | 0 | 2026-03-18 | |
| Havron Avraham | director | 2019-01-14 | 4.02 | 2026-03-18 | |
| Havron Avraham | director | 2023-05-02 | 6.39 | 2026-03-18 | |
| Bagley Bowman | officer: VP Commercial North America | 2026-03-18 | 0 | 2026-03-18 | |
| Abelis Bar Berta | officer: VP Legal | 2026-03-18 | 0 | 2026-03-18 | |
| Abelis Bar Berta | officer: VP Legal | 2026-03-18 | 0 | 2026-03-18 | |
| Abelis Bar Berta | officer: VP Legal | 2024-03-28 | 7.5 | 2026-03-18 | |
| Seror Jasmine | officer: VP Product Development | 2026-03-18 | 0 | 2026-03-18 | |
| Seror Jasmine | officer: VP Product Development | 2026-03-18 | 0 | 2026-03-18 | |
| Seror Jasmine | officer: VP Product Development | 2016-05-18 | 4.02 | 2026-03-18 | |
| Seror Jasmine | officer: VP Product Development | 2021-05-26 | 6.39 | 2026-03-18 | |
| Bensimon Philippe | officer: VP Regulations and QA | 2026-03-18 | 0 | 2026-03-18 | |
| Bensimon Philippe | officer: VP Regulations and QA | 2026-03-18 | 0 | 2026-03-18 | |
| Bensimon Philippe | officer: VP Regulations and QA | 2018-12-26 | 4.02 | 2026-03-18 | |
| Bensimon Philippe | officer: VP Regulations and QA | 2023-01-27 | 6.39 | 2026-03-18 | |
| Fahimipoor Oren | officer: VP Operations | 2026-03-18 | 0 | 2026-03-18 | |
| Fahimipoor Oren | officer: VP Operations | 2024-03-28 | 7.5 | 2026-03-18 | |
| Rotem Eran | officer: Deputy CEO and CFO | 2026-03-18 | 0 | 2026-03-18 | |
| Rotem Eran | officer: Deputy CEO and CFO | 2016-05-18 | 4.02 | 2026-03-18 | |
| Rotem Eran | officer: Deputy CEO and CFO | 2023-01-27 | 6.39 | 2026-03-18 |